Make these moves if volatility bothers you
Oct 06, 2021Same story we’ve been talking about for months now … rates are on the uptake which means stocks are set for a downdraft.
Here’s my playbook.
1 – How to “ace” volatility
Yesterday’s trading was about as strong as a snapback rally as we’ve seen in some time. Yet shares are set for a tumble as I type this morning because traders remain skittish about the Fed’s next move.
So what!
Short-term trading conditions do not void the case for owning the world’s best stocks.
Change up your tactics – selling cash-secured puts, using LowBall orders, taking some money off the table and realigning it … those are all GREAT things to be doing at a time like the present!
2 – Why I will not buy Facebook until Zuckerberg is out
I stopped by Mornings with Maria (Bartiromo) earlier today on the Fox Business Network and noted that I won’t be buying the stock until CEO Mark Zuckerberg is sent packing.
Here’s my thinking (watch now)
3 – Investing with a parachute
Many investors fear pullbacks but inexplicably do little or nothing to prepare for them ahead of time. That’s a shame because it’s an easily fixable situation.
Low-beta stocks can help smooth out the volatility that’s giving many investors a serious case of indigestion at the moment. Plus, many pay great dividends, too.
For example, Kellogg’s (K) has a beta of 0.62 which makes it 38% less volatile than the broader markets and shares currently reflect a forward yield of 3.60%. Striking workers could provide an interesting entry.
There are a few stocks I like even more and you know exactly what they are if you’re a One Bar Ahead™ subscriber. I’ll have a few thoughts this Friday in the Ask Me Anything’s.
4 – Could Pfizer’s Covid pill be better than Merck’s?
I think so and I am not alone in wondering. Merck beat ‘em to the punch with an oral treatment but Pfizer’s version may have a different safety profile. Merck’s pill is a repurposed flu drug while Pfizer’s pill is purpose-built to fight Covid. Molnupiravir, Merck’s pill inhibits virus replication while Pfizer’s PF-07321332 inhibits primary protease enzymes Covid needs to replicate.
My money is on Pfizer.
5 – $823 million reasons to own this stock
Buying the right stocks helps … Palantir (PLTR) just won an $823 million contract from the US Army and shares are still doing nothing. It’s only a matter of time until they will.
Zig when everybody else zags.
Bottom Line
It’s tempting to run for the hills, but history shows very clearly that the markets reward discipline over time.
Stay invested if you can.
Play offence every chance you get.
Chaos creates opportunity.
You got this – I promise!
As always, MAKE it a great day,
Keith